Nuvalent (NUVL)
(Delayed Data from NSDQ)
$84.96 USD
+0.38 (0.45%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $85.00 +0.04 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Nuvalent, Inc. (NUVL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$102.91 | $115.00 | $97.00 | 21.13% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Nuvalent, Inc. comes to $102.91. The forecasts range from a low of $97.00 to a high of $115.00. The average price target represents an increase of 21.13% from the last closing price of $84.96.
Analyst Price Targets (11)
Broker Rating
Nuvalent, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on 11 recommendations.
Of the 12 recommendations deriving the current ABR, 12 are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/NUVL.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 11 | 10 | 10 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/29/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
8/8/2024 | SVB Securities | Andrew Berens | Strong Buy | Strong Buy |
7/29/2024 | LifeSci Capital | Charles Zhu | Not Available | Strong Buy |
4/17/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/1/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
2/28/2024 | Guggenheim Securities | Kelsey Goodwin | Not Available | Strong Buy |
2/28/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Strong Buy |
2/23/2024 | Robert W. Baird & Co. | Colleen M Kusy | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 12 |
Average Target Price | $102.91 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.97 |
NUVL FAQs
Nuvalent, Inc. (NUVL) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Nuvalent, Inc. (NUVL) is $102.91. The current on short-term price targets is based on 6 reports.
The forecasts for Nuvalent, Inc. (NUVL) range from a low of $97 to a high of $115. The average price target represents a increase of $21.13 from the last closing price of $84.96.
The current UPSIDE for Nuvalent, Inc. (NUVL) is 21.13%
Based on short-term price targets offered by 11 analysts, the average price target for Nuvalent, Inc. comes to $102.91. The forecasts range from a low of $97.00 to a high of $115.00. The average price target represents an increase of 21.13% from the last closing price of $84.96.